Document Detail

Pretreatment Staging Positron Emission Tomography/Computed Tomography in Patients With Inflammatory Breast Cancer Influences Radiation Treatment Field Designs.
MedLine Citation:
PMID:  22284689     Owner:  NLM     Status:  Publisher    
PURPOSE: Positron emission tomography/computed tomography (PET/CT) is increasingly being utilized for staging of inflammatory breast cancer (IBC). The purpose of this study was to define how pretreatment PET/CT studies affected postmastectomy radiation treatment (PMRT) planning decisions for IBC. METHODS AND MATERIALS: We performed a retrospective analysis of 62 patients diagnosed with IBC between 2004 and 2009, who were treated with PMRT in our institution and who had a staging PET/CT within 3 months of diagnosis. Patients received a baseline physical examination, staging mammography, ultrasonographic examination of breast and draining lymphatics, and chest radiography; most patients also had a bone scan (55 patients), liver imaging (52 patients), breast MRI (46 patients), and chest CT (25 patients). We compared how PET/CT findings affected PMRT, assuming that standard PMRT would target the chest wall, level III axilla, supraclavicular fossa, and internal mammary chain (IMC). Any modification of target volumes, field borders, or dose prescriptions was considered a change. RESULTS: PET/CT detected new areas of disease in 27 of the 62 patients (44%). The areas of additional disease included the breast (1 patient), ipsilateral axilla (1 patient), ipsilateral supraclavicular (4 patients), ipsilateral infraclavicular (1 patient), ipsilateral IMC (5 patients), ipsilateral subpectoral (3 patients), mediastinal (8 patients), other distant/contralateral lymph nodes (15 patients), or bone (6 patients). One patient was found to have a non-breast second primary tumor. The findings of the PET/CT led to changes in PMRT in 11 of 62 patients (17.7%). These changes included additional fields in 5 patients, adjustment of fields in 2 patients, and higher doses to the supraclavicular fossa (2 patients) and IMC (5 patients). CONCLUSIONS: For patients with newly diagnosed IBC, pretreatment PET/CT provides important information concerning involvement of locoregional lymph nodes, mediastinal lymph nodes, and unsuspected sites of distant metastasis. This information is important in the design of radiotherapy treatment fields and, therefore, we recommend that PET/CT be a component of initial staging for IBC.
Gary V Walker; Naoki Niikura; Wei Yang; Eric Rohren; Vicente Valero; Wendy A Woodward; Ricardo H Alvarez; Anthony Lucci; Naoto T Ueno; Thomas A Buchholz
Related Documents :
22070159 - Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care-...
20512089 - Predictive value of routine transcutaneous tissue oxygen tension (tcpo2) measurement fo...
1830409 - Evidence for raynaud's syndrome among haemodialyzed patients: influence of flunarizine ...
9685139 - Smoking, hemorheologic factors, and progression of peripheral arterial disease in patie...
12579 - A metabolic approach to the evaluation of peripheral vascular disease.
3440609 - Treatment in serious lower limb injuries: amputation versus preservation.
21474939 - Folate and homocysteine in the cerebrospinal fluid of patients with alzheimer's disease...
17502699 - Red blood cell deformability in patients with sepsis: a marker for prognosis and monito...
24147939 - Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-25
Journal Detail:
Title:  International journal of radiation oncology, biology, physics     Volume:  -     ISSN:  1879-355X     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7603616     Medline TA:  Int J Radiat Oncol Biol Phys     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluation of Field-in-Field Technique for Total Body Irradiation.
Next Document:  Lhermitte sign after chemo-IMRT of head-and-neck cancer: incidence, doses, and potential mechanisms.